Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: Risk factors, pathogenesis, prognosis and treatment (an American ophthalmological society thesis)

Transactions of the American Ophthalmological Society

Volumn 112, Issue , 2014, Pages 142-159

  Sarraf, David ^a,b,c   Joseph, Anthony ^a   Rahimy, Ehsan ^a,d  

^a JULES STEIN EYE INSTITUTE   (United States)

^b KAISER PERMANENTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MALE; OCULAR FIBROSIS; PATHOGENESIS; PATIENT MONITORING; PROGNOSIS; RETINA DETACHMENT; RETINA MACULA HEMORRHAGE; RETINA TEAR; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; VISUAL ACUITY; VISUAL ACUITY CHART; ANTAGONISTS AND INHIBITORS; CASE REPORT; COMPLICATION; INTRAVITREAL DRUG ADMINISTRATION; MACULAR DEGENERATION; MIDDLE AGED; RETINAL PERFORATIONS;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BEVACIZUMAB; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROGNOSIS; RANIBIZUMAB; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84922506067     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Levin LA, Seddon JM, Topping T. Retinal pigment epithelial tears associated with trauma. Am J Ophthalmol 1991;112(4):396-400.
2. Chan A, Duker JS, Ko TH, Schuman JS, Fujimoto JG. Ultra-high resolution optical coherence tomography of retinal pigment epithelial tear following blunt trauma. Arch Ophthalmol 2006;124(2):281-283.
3. Doi M, Osawa S, Sasoh M, Uji Y. Retinal pigment epithelial tear and extensive exudative retinal detachment following blunt trauma. Graefes Arch Clin Exp Ophthalmol 2000;238(7):621-624.
4. Fryczkowski P, Jedruch A, Kmera-Muszynska M. Spontaneous RPE tear in high myopia. Klin Oczna 2006;108(7-9):327-331.
5. Chang LK, Sarraf D. Tears of the retinal pigment epithelium: an old problem in a new era. Retina 2007;27(5):523-534.
6. Lim JI, Lam S. A retinal pigment epithelium tear in a patient with angioid streaks. Arch Ophthalmol 1990;108(12):1672-1674.
7. Leys AM, Shields JA. Tumor-associated retinal pigment epithelial tears. Retina 1997;17(3):258-260.
8. Leys A. Choroidal metastasis and retinal pigment epithelial tear in a patient with small cell lung carcinoma. Retina 2000;20(2):216-217.
9. Mames RN, Margo CE. Retinal pigment epithelial tear after treatment of metastatic carcinoma of the choroid. Retina 1991;11(4):430-432.
10. Spielberg LH, Heckenlively JR, Leys AM. Retinal pigment epithelial detachments and tears, and progressive retinal degeneration in light chain deposition disease. Br J Ophthalmol 2013;97(5):627-631.
11. Shanmugam MP, Bhende M. Retinal pigment epithelial tears associated with idiopathic central serous chorioretinopathy. Indian J Ophthalmol 2000;48(4):315-317.
12. Ishida Y, Kato T, Minamoto A, Yokoyama T, Jian K, Mishima HK. Retinal pigment epithelial tear in a patient with central serous chorioretinopathy treated with corticosteroids. Retina 2004;24(4):633-636.
13. Lee SB, Kim JY, Kim WJ, Cho CB, Iwase T, Jo YJ. Bilateral central serous chorioretinopathy with retinal pigment epithelium tears following epidural steroid injection. Indian J Ophthalmol 2013;61(9):514-515.
14. Musashi K, Tsujikawa A, Hirami Y, et al. Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy. Am J Ophthalmol 2007;143(5):883-885.
15. Pauleikhoff D, Loffert D, Spital G, et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002;240(7):533-538.
16. Tsujikawa A, Hirami Y, Nakanishi H, et al. Retinal pigment epithelial tear in polypoidal choroidal vasculopathy. Retina 2007;27(7):832-838.
17. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol 1981;65(6):417-422.
18. Karadimas P, Paleokastritis GP, Bouzas EA. Fundus autofluorescence imaging findings in retinal pigment epithelial tear. Eur J Ophthalmol 2006;16(5):767-769.
19. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103(8):1260-1270.
20. Giovannini A, Amato G, Mariotti C, Scassellati-Sforzolini B. Optical coherence tomography in the assessment of retinal pigment epithelial tear. Retina 2000;20(1):37-40.
21. Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Am J Ophthalmol 2013;156(5):981-988.e982.
22. Sarraf D, Reddy S, Chiang A, Yu F, Jain A. A new grading system for retinal pigment epithelial tears. Retina 2010;30(7):1039-1045.
23. Chuang EL, Bird AC. Repair after tears of the retinal pigment epithelium. Eye 1988;2(Pt 1):106-113.
24. Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 1985;69(6):397-403.
25. Meyer CH, Toth CA. Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature. Graefes Arch Clin Exp Ophthalmol 2001;239(5):325-333.
26. Chan CK, Meyer CH, Gross JG, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 2007;27(5):541-551.
27. Koenig F, Soubrane G, Coscas G. Retinal pigment epithelial tears after photocoagulation in age-related macular degeneration. J Fr Ophtalmol 1989;12(11):775-780.
28. Norose K, Tanino T, Segawa K. Bilateral tears of the retinal pigment epithelium. Br J Ophthalmol 1988;72(8):621-627.
29. Gass JD. Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 1984;98(6):700-706.
30. Kim SW, Oh J, Oh IK, Huh K. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 2009;40(3):300-303.
31. Goldstein M, Heilweil G, Barak A, Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye 2005;19(12):1315-1324.
32. Shima C, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Tano Y. One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration. Graefes Arch Clin Ophthalmol 2009;247(7):899-906.
33. Srivastava SK, Sternberg P Jr. Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia. Retina 2002;22(5):669-671.
34. Michels S, Aue A, Simader C, Geitzenauer W, Sacu S, Schmidt-Erfurth U. Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol 2006;141(2):396-398.
35. Chang LK, Flaxel CJ, Lauer AK, Sarraf D. RPE tears after pegaptanib treatment in age-related macular degeneration. Retina 2007;27(7):857-863.
36. Chan CK, Abraham P, Meyer CH, et al. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina 2010;30(2):203-211.
37. Mennel S, Callizo J, Schmidt JC, Meyer CH. Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin) injections. Acta Ophthalmol Scand 2007;85(6):689-691.
38. Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 2006;90(9):1207-1208.
39. Nicolo M, Ghiglione D, Calabria G. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). Eur J Ophthalmol 2006;16(5):770-773.
40. Shah CP, Hsu J, Garg SJ, Fischer DH, Kaiser R. Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 2006;142(6):1070-1072.
41. Spandau UH, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006;142(6):1068-1070.
42. Leitritz M, Gelisken F, Inhoffen W, Voelker M, Ziemssen F. Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye 2008;22(12):1504-1507.
43. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 2006;84(6):833-834.
44. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU, Inhoffen W. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye 2009;23(3):694-702.
45. Gibran SK, Sachdev A, Stappler T, Newsome R, Wong D, Hiscott P. Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol 2007;91(5):602-604.
46. Gamulescu MA, Framme C, Sachs H. RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD. Graefes Arch Clin Exp Ophthalmol 2007;245(7):1037-1040.
47. Bakri SJ, Patel SP. Retinal pigment epithelial tear following intravitreal bevacizumab. Eye 2007;21(3):424-425.
48. Ronan SM, Yoganathan P, Chien FY, et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Retina 2007;27(5):535-540.
49. Bakri SJ, Kitzmann AS. Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol 2007;143(3):505-507.
50. Lee GK, Lai TY, Chan WM, Lam DS. Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007;245(8):1225-1227.
51. Carvounis PE, Kopel AC, Benz MS. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 2007;143(3):504-505.
52. Cunningham ET Jr, Feiner L, Chung C, Tuomi L, Ehrlich JS. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration. Ophthalmology 2011;118(12):2447-2452.
53. Kiss C, Michels S, Prager F, Geitzenauer W, Schmidt-Erfurth U. Retinal pigment epithelium tears following intravitreal ranibizumab therapy. Acta Ophthalmol Scand 2007;85(8):902-903.
54. Konstantinidis L, Ambresin A, Zografos L, Mantel I. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration. Acta Ophthalmol 2010;88(7):736-741.
55. Figurska M. Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration. Med Sci Monit 2012;18(1):CR32-38.
56. Apte RS. Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD. Int Ophthalmol 2007;27(1):59-61.
57. Smith BT, Kraus CL, Apte RS. Retinal pigment epithelial tears in ranibizumab-treated eyes. Retina 2009;29(3):335-339.
58. Sarraf D, Chan C, Rahimy E, Abraham P. Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy. Retina 2013;33(8):1551-1557.
59. Saito M, Kano M, Itagaki K, Oguchi Y, Sekiryu T. Retinal pigment epithelium tear after intravitreal aflibercept injection. Clin Ophthalmol 2013;7:1287-1289.
60. Bertelmann T, Sekundo W, Wenner Y. Tear in the retinal pigment epithelium by intravitreal injection of aflibercept. Ophthalmologe 2014;111(8):775-555.
61. Doguizi S, Ozdek S. Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration. Retina 2014;34(6):1156-1162.
62. Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 2008;28(9):1265-1269.
63. Asao K, Gomi F, Sawa M, Nishida K. Additional anti-vascular endothelial growth factor therapy for eyes with a retinal pigment epithelial tear after the initial therapy. Retina 2014;34(3):512-518.
64. Coco RM, Sanabria MR, Hernandez AG, Fernandez Munoz M. Retinal pigment epithelium tears in age-related macular degeneration treated with antiangiogenic drugs: a controlled study with long follow-up. Ophthalmologica 2012;228(2):78-83.
65. Gutfleisch M, Heimes B, Schumacher M, et al. Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD. Eye 2011;25(9):1181-1186.
66. Singh RP, Sears JE. Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 2006;142(1):160-162.
67. Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006;141(4):752-754.
68. Mitamura Y, Ogata K, Oshitari T, Asaumi N, Yamamoto S. Retinal detachment with macular hole following intravitreal bevacizumab in patient with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92(5):717-718.
69. Arevalo JF, Maia M, Flynn HW Jr, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92(2):213-216.
70. Oshima Y, Shima C, Wakabayashi T, et al. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology 2009;116(5):927-938.
71. Yeh PT, Yang CM, Lin YC, Chen MS, Yang CH. Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy. Retina 2009;29(6):768-774.
72. Sohn EH, He S, Kim LA, et al. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1. Arch Ophthalmol 2012;130(9):1127-1134.
73. Van Geest RJ, Lesnik-Oberstein SY, Tan HS, et al. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol 2012;96(4):587-590.
74. Kuiper EJ, Van Nieuwenhoven FA, de Smet MD, et al. The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PloS One 2008;3(7):e2675.
75. Bloch SB, Bedda A, Abdel Hadi AM, Larsen M. Contraction of occult choroidal neovascular membrane and rupture of the retinal pigment following verteporfin and bevacizumab treatment. Acta Ophthalmol 2011;89(8):e665-666.
76. Clemens CR, Bastian N, Alten F, Milojcic C, Heiduschka P, Eter N. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment. Acta Ophthalmol 2014;92(1):e50-56.
77. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 2009;147(4):644-652.
78. Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007;27(5):589-594.
79. Khan S, Engelbert M, Imamura Y, Freund KB. Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina 2012;32(6):1057-1068.
80. Toth CA, Pasquale AC 3rd, Graichen DF. Clinicopathologic correlation of spontaneous retinal pigment epithelial tears with choroidal neovascular membranes in age-related macular degeneration. Ophthalmology 1995;102(2):272-277.
81. Lafaut BA, Aisenbrey S, Vanden Broecke C, et al. Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol 2001;85(4):454-460.
82. Cantrill HL, Ramsay RC, Knobloch WH. Rips in the pigment epithelium. Arch Ophthalmol 1983;101(7):1074-1079.
83. Krishan NR, Chandra SR, Stevens TS. Diagnosis and pathogenesis of retinal pigment epithelial tears. Am J Ophthalmol 1985;100(5):698-707.
84. Mrejen S, Sarraf D, Mukkamala SK, Freund KB. Multimodal imaging of pigment epithelial detachment: a guide to evaluation. Retina 2013;33(9):1735-1762.
85. Coscas F, Coscas G, Souied E, Tick S, Soubrane G. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2007;144(4):592-599.
86. Rahimy E, Freund KB, Larsen M, et al. Multilayered pigment epithelial detachment in neovascular AMD. Retina 2014;34(7):1289-1295.
87. Schlingemann RO, van Hinsbergh VW. Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol 1997;81(6):501-512.
88. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108(Pt 6):2369-2379.
89. Couffinhal T, Kearney M, Witzenbichler B, et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997;150(5):1673-1685.
90. Kimoto K, Kubota T. Anti-VEGF agents for ocular angiogenesis and vascular permeability. J Ophthalmol 2012;2012:852183.
91. Varshney N, Jain A, Chan V, Yu L, Sarraf D. Anti-VEGF response in macular hemorrhage and incidence of retinal pigment epithelial tears. Can J Ophthamol 2013;48(3):210-215.
92. Schoeppner G, Chuang EL, Bird AC. The risk of fellow eye visual loss with unilateral retinal pigment epithelial tears. Am J Ophthalmol 1989;108(6):683-685.
93. Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 2013;120(11):2292-2299.
94. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009;116(1):57-65.e55.
95. Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge J, Blodi B. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology 2011;118(3):523-530.
96. Singer MA, Awh CC, Sadda S, et al. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2012;119(6):1175-1183.
97. Dunavoelgyi R, Sacu S, Eibenberger K, et al. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results. Retina 2012;32(8):1471-1479.
98. Chuang EL, Bird AC. Bilaterality of tears of the retinal pigment epithelium. Br J Ophthalmol 1988;72(12):918-920.
99. Polito A, Cereda M, Romanelli F, Pertile G. Macular translocation with 360 degrees retinotomy for management of retinal pigment epithelial tear: long-term results. Br J Ophthalmol 2011;95(1):74-78.
100. Maaijwee K, Joussen AM, Kirchhof B, van Meurs JC. Retinal pigment epithelium (RPE)-choroid graft translocation in the treatment of an RPE tear: preliminary results. Br J Ophthalmol 2008;92(4):526-529.